Open AccessAntihypertensive treatments in adult autosomal dominant polycystic kidney disease: network meta-analysis of the randomized controlled trials
Author(s) -
Cheng Xue,
Chenchen Zhou,
Bing Dai,
Shengqiang Yu,
Chao Xu,
Zhiguo Mao,
Chaoyang Ye,
Dongping Chen,
Xiaona Zhao,
Jun Wu,
Wansheng Chen,
Changlin Mei
Publication year - 2015
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.6452
Subject(s) - medicine , autosomal dominant polycystic kidney disease , renal function , blood pressure , randomized controlled trial , creatinine , urology , ramipril , albuminuria , meta analysis , cardiology , kidney
Blood pressure (BP) control is one of the most important treatments of Autosomal dominant polycystic kidney disease (ADPKD). The comparative efficacy of antihypertensive treatments in ADPKD patients is inconclusive.